Last reviewed · How we verify
Progesterone in oil
At a glance
| Generic name | Progesterone in oil |
|---|---|
| Sponsor | Toronto Centre for Advanced Reproductive Technology |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PRogrammed Versus Modified Natural Cycle After Euploid Failed Embryo Transfer (NA)
- Endometrial Preparation in Frozen Embryo Transfer Cycles (PHASE4)
- Randomized Trial of Maternal Progesterone Therapy (PHASE2)
- Uterine Contractions and Mode of Progesterone in Frozen Embryo Transfer (FET) Cycles: Randomized Clinical Trial (NA)
- Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery (PHASE3)
- The Outcome of Two Protocols Used to Prepare Endometrium for Frozen Embryo Transfer (PHASE4)
- Effects of E2, P4 and LH Levels on the Day of Transfer and Endometrial Cavity Thickness on Implantation Success in Patients With Frozen-thawed Embryo Transfer Cycle (NA)
- Luteal Support in Frozen-Thawed Embryo Transfer Cycles (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Progesterone in oil CI brief — competitive landscape report
- Progesterone in oil updates RSS · CI watch RSS
- Toronto Centre for Advanced Reproductive Technology portfolio CI